Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation.

Castleman disease (CD) was first described in the 1954 by Benjamin Castleman as a rare nonmalignant lymphoproliferative disorder [1]. Multicentric CD (MCD) involves multiple regions of enlarged lym...